The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Nuvo Pharmaceuticals Inc up $0.05

Nuvo Pharmaceuticals Inc closed up Friday by $0.05 or 0.75% to $6.75. Shares have lost 1.46% over the last five days, but have gained 29.56% over the last year to date. This security has outperformed the S&P TSX by 23.03% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward8.54×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.46
Updated May 27 2:41 PM EDT. Delayed by at least 15 minutes.


Net Profit (TTM)

Nuvo Pharmaceuticals Inc has a net profit margin of -19.97%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.40%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Total other revenue--------
Total revenue8863
Gross profit5531
Total cost of revenue3332
Total operating expense5879
Selling / general / administrative2333
Research & development0224
Depreciation / amortization0000
Interest expense (income), net operating--000
Unusual expense (income)--00--
Other operating expenses, total--------
Operating income20-2-6
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--0----
Income before tax20-1-6
Income after tax20-1-6
Income tax, total0000
Net income-10-1-6
Total adjustments to net income--------
Net income before extra. items20-1-6
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items20-1-6
Inc. avail. to common incl. extra. items-10-1-6
Diluted net income-10-1-6
Dilution adjustment--------
Diluted weighted average shares11111111
Diluted EPS excluding extraordinary itemsvalue per share0.170.03-0.11-0.55
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.170.03-0.11-0.55